SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041033
Filing Date
2019-11-06
Accepted
2019-11-06 16:16:46
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3 2019 harp-10q_20190930.htm 10-Q 2880704
2 EX-31.1 harp-ex311_9.htm EX-31.1 23030
3 EX-31.2 harp-ex312_7.htm EX-31.2 23033
4 EX-32.1 harp-ex321_8.htm EX-32.1 11808
  Complete submission text file 0001564590-19-041033.txt   8364205

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT harp-20190930.xml EX-101.INS 1661777
6 XBRL TAXONOMY EXTENSION SCHEMA harp-20190930.xsd EX-101.SCH 51187
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE harp-20190930_cal.xml EX-101.CAL 50138
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE harp-20190930_def.xml EX-101.DEF 194885
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20190930_lab.xml EX-101.LAB 431237
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20190930_pre.xml EX-101.PRE 332530
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 191196515
SIC: 2836 Biological Products, (No Diagnostic Substances)